[What increase of transaminases can be tolerated in chenodeoxycholic acid therapy?].
D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D002635:Chenodeoxycholic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy; D005260:Female; D006801:Humans
D002635:Chenodeoxycholic Acid; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Welche Steigerung der Transaminasen kann bei Chenodesoxycholsäure-Therapie toleriert werden